(222 days)
Not Found
No
The summary describes a physical cryo-ablation probe and its intended use, with no mention of AI or ML in the device description, intended use, or performance studies. The "Mentions AI, DNN, or ML" field is explicitly marked as "Not Found".
Yes
The device is described as being used for the "cryosurgical treatment of cardiac arrhythmias" and "freezes target tissues, creating an inflammatory response (cryonecrosis) that blocks the electrical conduction pathway," which are therapeutic actions.
No
The device is described as a cryo-ablation probe used for surgical treatment by freezing target tissues to block electrical conduction. Its purpose is therapeutic (treatment), not diagnostic (identifying or characterizing a condition).
No
The device description clearly states it is a "cryo-ablation probe," which is a physical hardware device used for cryosurgery. It is not software.
Based on the provided information, the Cryo1 cryo-ablation probe is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use clearly states it's for the "cryosurgical treatment of cardiac arrhythmias." This is a therapeutic procedure performed directly on the patient's body.
- Device Description: The description reinforces its use in conjunction with a console to "freeze target tissue," again indicating a direct intervention on the patient.
- Lack of IVD Characteristics: There is no mention of the device being used to examine specimens (like blood, urine, or tissue samples) outside of the body to provide information for diagnosis, monitoring, or screening.
IVD devices are used in vitro (in glass, or outside the living organism) to analyze samples and provide diagnostic information. The Cryo1 probe is used in vivo (within the living organism) for treatment.
N/A
Intended Use / Indications for Use
The Cryo1 cryo-ablation probe is a sterile, single use device intended for use in the cryosurgical treatment of cardiac arrhythmias. The probe freezes target tissues, creating an inflammatory response (cryonecrosis) that blocks the electrical conduction pathway.
Product codes (comma separated list FDA assigned to the subject device)
GEH
Device Description
The Cryo1 cryo-ablation probe is a sterile, single use, cryosurgical device to be used in conjunction with the frigitronics CCS-200 Cardiac Cryosurgical Console to freeze target tissue, blocking the electrical conduction pathways by creating an inflammatory response or cryonecrosis.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
cardiac
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Appropriate product testing was conducted to evaluate conformance to product specification and substantial equivalence to predicate devices.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 878.4350 Cryosurgical unit and accessories.
(a)
Identification —(1)Cryosurgical unit with a liquid nitrogen cooled cryoprobe and accessories. A cryosurgical unit with a liquid nitrogen cooled cryoprobe and accessories is a device intended to destroy tissue during surgical procedures by applying extreme cold.(2)
Cryosurgical unit with a nitrous oxide cooled cryoprobe and accessories. A cryosurgical unit with a nitrous oxide cooled cryoprobe and accessories is a device intended to destroy tissue during surgical procedures, including urological applications, by applying extreme cold.(3)
Cryosurgical unit with a carbon dioxide cooled cryoprobe or a carbon dioxide dry ice applicator and accessories. A cryosurgical unit with a carbon dioxide cooled cryoprobe or a carbon dioxide dry ice applicator and accessories is a device intended to destroy tissue during surgical procedures by applying extreme cold. The device is intended to treat disease conditions such as tumors, skin cancers, acne scars, or hemangiomas (benign tumors consisting of newly formed blood vessels) and various benign or malignant gynecological conditions affecting vulvar, vaginal, or cervical tissue. The device is not intended for urological applications.(b)
Classification. Class II.
0
K082074
page 1/1
CRYO1 CRYO-ABLATION PROBE 510(k) SUMMARY
General Information
| Classification | Class II | MAR - 2 2009 |
|---|---|---|
| Trade Name | Cryo1 cryo-ablation probe | |
| Manufacturer | AtriCure, Inc | |
| 6033 Schumacher Park Dr | ||
| West Chester, OH 45069 | ||
| Contact | James L. Lucky | |
| VP of Quality Assurance and Regulatory Affairs |
Indications for Use
The Cryo1 cryo-ablation probe is a sterile, single use device intended for use in the cryosurgical treatment of cardiac arrhythmias. The probe freezes target tissues, creating an inflammatory response (cryonecrosis) that blocks the electrical conduction pathway.
Predicate Devices
The predicate devices for the Cryo1 cryo-ablation probe are the frigitronics CCS-200 Cardiac Cryosurgical System 3011 Maze Linear Probe (K811390), the Heartport Maze System (K970496) and the CryoCath SurgiFrost Cryosurgical 10cm Device (K053436).
Device Description
The Cryo1 cryo-ablation probe is a sterile, single use, cryosurgical device to be used in conjunction with the frigitronics CCS-200 Cardiac Cryosurgical Console to freeze target tissue, blocking the electrical conduction pathways by creating an inflammatory response or cryonecrosis.
Materials
All materials used in the manufacture of the Crvo-ablation probe are suitable for this use and have been used in numerous previously cleared products. Testing was conducted in accordance with ISO 10993-1 to ensure appropriate biocompatibility of all materials.
Testing
Appropriate product testing was conducted to evaluate conformance to product specification and substantial equivalence to predicate devices.
Summary of Substantial Equivalence
The Cryo1 cryo-ablation probe is equivalent to the predicate products. The indications for use, basic overall function, and materials used are substantially equivalent.
1
DEPARTMENT OF HEALTH & HUMAN SERVICES
Image /page/1/Picture/1 description: The image shows the seal of the Department of Health & Human Services (HHS) of the United States. The seal features a stylized eagle with outstretched wings, symbolizing protection and service. The words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" are arranged in a circular pattern around the eagle.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
Atricure Inc. c/o Mr. Mark Job Reviewer Regulatory Technology Services, LLC 1394 25th Street NW Buffalo, MN 55313
MAR - 2 2009
Re: K082074
Trade/Device Name: Cryo1 cryo-ablation probe Regulation Number: 21 CFR 878.4350 Regulation Name: Cryosurgical unit and accessories Regulatory Class: Class II (two) Product Code: GEH Dated: February 12, 2009 Received: February 13, 2009
Dear Mr. Job:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the iddications for use stated in the enclosure) to legally marketed predicate devices marketed in intenstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendmonts, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the 1 (1 ) The general controls provisions of the Act include requirements for annual registrotion, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your devire can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, TDAAmount publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act
2
Page 2 - Mr. Mark Job
or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Center for Devices and Radiological Health's (CDRH's) Office of Compliance at (240) 276-0120. Also, please note the regulation entitled. "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding postmarket surveillance, please contact CDRH's Office of Surveillance and Biometrics' (OSB's) Division of Postmarket Surveillance at 240-276-3474. For questions regarding the reporting of device adverse events (Medical Device Reporting (MDR)), please contact the Division of Surveillance Systems at 240-276-3464. You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (240) 276-3150 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.
Sincerely yours.
Mark Tellem for
D. Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
3
Indications for Use
510(k) Number (if known) K082074
Device Name: Cryo1 cryo-ablation probe
Indications for Use:
The Cryo1 cryo-ablation probe is a sterile, single use device intended for use in the cryosurgical treatment of cardiac arrhythmias. The probe freezes target tissues, creating an inflammatory response (cryonecrosis) that blocks the electrical conduction pathway.
Prescription Use × (Part 21 CRF 801 Subpart D)
AND/OR
Over-The-Counter Use (21 CRF 807 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Mark Helin
Sigh-Off Division of Cardiovascular Devices K082074 510(k) Number
AtriCure, Inc.